NCT02028988View on ClinicalTrials.gov

Enzalutamide + External Beam Rt For Prostate

PHASE2CompletedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

October 31, 2017

Study Completion Date

January 31, 2018

Conditions

Intermediate Risk Prostate Cancer

Interventions

DRUG

Enzalutamide

RADIATION

External Beam Radiation

Trial Locations (3)

02115

Beth Israel Deaconess Medical Center, Boston

Brigham and Women's Hospital, Boston

Dana Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

Medivation, Inc.

All Listed Sponsors

collaborator

Medivation, Inc.

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER